.
ER Editor: See The Vigilant Fox on this —
Pfizer Bows to Trump in ‘Historic’ Drug Price-Cutting Deal
This article presents the price cuts as a triumph across the board, and Albert Bourla (a stand-in, a 2.0 by now) being brought to heel. Important White House Optics. Look at the nodding dog, Bourla, in this video —
🚨 BREAKING: President Trump just announced he’s struck a deal with Pfizer to offer MASSIVE discounts on their drugs, follow his demands to lower prices for Americans
A new government website, TrumpRx, will also be available for consumers to DIRECTLY purchase drugs, cutting out… pic.twitter.com/kUbiNeXGXo
— Nick Sortor (@nicksortor) September 30, 2025
***
Dr. Nicolas Hulscher isn’t so jubilant below, however:
Pfizer Strikes $70 Billion Deal with U.S. to Expand Its mRNA Empire, Lower Drug Prices
In reality, it appears to be a multi-billion dollar effort to entrench Pfizer’s failed gene-transfer platforms for decades to come.
The deal secures a $70 billion commitment to U.S. R&D — a down payment on Pfizer’s next wave of gene-based products:
- Cancer “vaccines”
- Obesity injections
- Expanded vaccine portfolio (flu, RSV, bird flu, more)
- Chronic disease biologics in inflammation & immunology
Pfizer itself spelled it out:
“With this agreement in place, Pfizer can fully focus on delivering the next generation of cures… in areas like oncology, obesity, vaccines, and inflammation and immunology.”
This comes after Pfizer’s COVID-19 gene-based products have already been linked to catastrophic injuries, deaths, and disabilities worldwide. Instead of scrutiny, the company is rewarded with protection and growth.
CEO Albert Bourla called the deal a “win for patients, a win for leadership, and a win for Pfizer.” He’s right about the last part.
By pledging billions in “investment,” Pfizer secured tariff relief, regulatory stability, and political cover to expand its mRNA pipeline — despite the obvious trail of death and destruction its previous and current products left behind.
The message is clear: accountability is off the table, and Pfizer’s genetic empire now stands shielded by the U.S. government itself.
***
Karen Kingston focuses on how Trump’s plan keeps Pharma investment in R&D and manufacturing within the US instead of yet again being gifted to China. See —
Pfizer Brings US BioPharma Investment to More than $230 Billion By 2030
Her concluding thought, however:
Unless Americans restore their health with good nutrition, exercise, and other healthy habits, and stop relying on the BioPharma industry for drugs and vaccines, the BioPharma giants aren’t going to go anywhere.
***
🚨 JUST IN: President Trump is set to announce the launch of TrumpRx, which is a new website to allow Americans to buy discounted drugs for CASH
This will cut out the middleman, and lower prices of drugs, as users can search for specific drugs from multiple different… pic.twitter.com/0ZriZZgnz2
— Nick Sortor (@nicksortor) September 30, 2025
********
Watch Live: Trump Touts Drug-Price Deal
Watch Live:
* * *
Shares of pharmaceutical giant Pfizer sprinted higher in early trade Tuesday after reports that later today, President Trump and CEO Albert Bourla, will announce that the company will sell drugs at lower prices to the US Medicaid insurance program as part of a deal to advance the Trump administration’s “most favored nations” agenda.
The program is an effort to link US drug prices to the lowest cost of drugs paid by the wealthiest countries – and is linked to a May executive order that laid out the initiative, WaPo reports. Administration officials have been in negotiations with big pharma to get them to voluntarily lower their prices, which had a Monday deadline.
Bourla is also expected to announce a $70 billion investment on manufacturing medications in the USA, according to Pfizer spokeswoman Amy Rose and a White House official.
“It’s a win for American patients, a win for American leadership, and it’s a win for Pfizer because it provides the certainty and stability we need to continue advancing new breakthrough medicines for patients,” Rose said in a statement.
The move coincides with a direct-to-consumer website for Americans to buy drugs, dubbed TrumpRX – which would allow people to pay cash for certain drugs directly from a government website at a discounted price negotiated by the government.
“We pay much higher for drugs than the rest of the world. We subsidize the rest of the world,” Trump said last week. “We’re not doing that anymore and that’s a big thing.”
Trump has long argued that the United States government spends too much on medications and pursued a similar drug-pricing plan during his first term. His administration has sought to pressure the pharmaceutical industry through a mix of tariffs and new initiatives, such as several pilot programs being developed by the Centers for Medicare and Medicaid Services that could impose new drug-pricing controls in the Medicare program, according to four people who spoke on the condition of anonymity to detail those pilot programs. -WaPo
And according to the Wall Street Journal, other companies are expected to follow suit.
“President Trump is leveraging the power of the federal government to drastically cut drug prices for everyday Americans,” said White House spokesman Kush Desai. “Democrats talked the talk for decades about drug prices, but only President Trump is actually walking the walk.”
The pharmaceutical industry has sought to make concessions – with their main lobbying group – the Pharmaceutical Research and Manufacturers of America on Monday announcing a series of voluntary steps to support Trump’s goals.
Developing…
Source
Featured image source, Trump: https://x.com/nicksortor/status/1973031990120054904/photo/1
Featured image source, Bourla: https://www.statnews.com/2025/09/30/what-behind-pfizer-trump-drug-price-deal/
************
••••
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
••••
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
••••
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
••••
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Leave a Reply